益生菌活菌制剂联合肠内营养治疗重症脑卒中患者的临床效果

发布时间：2018-05-02 11:20

本文选题：益生菌活菌制剂 + 肠内营养　；参考：《中国药物经济学》2016年11期

【摘要】：目的探讨益生菌活菌制剂联合肠内营养治疗重症脑卒中患者的临床效果。方法选取2012年3月至2016年3月辽宁省本溪市中心医院收治的120例重症脑卒中患者作为研究对象,按随机数字表法将其分为试验组与对照组,各60例。对照组患者实施肠内营养支持治疗,试验组患者在对照组基础上采用益生菌活菌制剂进行治疗,比较两组患者治疗效果。结果试验组患者的不良反应发生率明显低于对照组,差异有统计学意义(P0.05);试验组患者消化道出血、肺部感染及泌尿系统感染发生率均明显低于对照组,差异均有统计学意义(均P0.05);试验组患者营养液达供给量时间明显短于对照组,菌群失调率明显低于对照组,差异均有统计学意义(均P0.05)。结论针对重症脑卒中患者,在肠内营养支持治疗基础上,联合益生菌活菌制剂进行治疗,效果显著且安全可靠。
[Abstract]:Objective to investigate the clinical effect of probiotics combined with enteral nutrition in the treatment of severe stroke patients. Methods from March 2012 to March 2016, 120 patients with severe stroke were selected from Benxi Central Hospital of Liaoning Province as study objects. They were divided into experimental group and control group with 60 cases each. The patients in the control group were treated with enteral nutrition support, and the patients in the experimental group were treated with probiotics on the basis of the control group. Results the incidence of adverse reactions in the trial group was significantly lower than that in the control group (P 0.05), and the incidence of gastrointestinal bleeding, pulmonary infection and urinary tract infection in the trial group was significantly lower than that in the control group. The difference was statistically significant (all P 0.05), the time of reaching the supply of nutrient solution in the test group was significantly shorter than that in the control group, and the maladjustment rate of bacterial flora was significantly lower than that in the control group (all P 0.05). Conclusion on the basis of enteral nutrition support, combined with probiotics is effective and safe for patients with severe cerebral apoplexy.
【作者单位】：辽宁省本溪市中心医院;
【分类号】：R743.3

【相似文献】